Effexor XR has won FDA approval to treat social anxiety disorder - venlafaxine - Product News in Brief - Brief Article

Drug Cost Management Report, March, 2003

* Effexor XR (venlafaxine) has won FDA approval to treat social anxiety disorder. Wyeth-Ayerst's antidepressant Effexor XR is the first of its class (serotonin-norepinephrine reuptake inhibitors) to be approved for this condition. Social anxiety disorder is the third most common psychiatric disorder in the U.S., affecting approximately 10 million Americans.

Information: www.effexorxr.com.